ERBB2 and breast carcinoma: Previously, Kavarthapu et al. reported that increased JAK2 expression might lead to HER2 phosphorylation and promote the proliferation of HER2-positive breast cancer cells through downstream MEK/ERK and PI3K/AKT pathways [52].